Abstract:OBJECTIVE:To explore the effect of the phosphoinositide 3-kinase/protein kinase B (PI3K/PKB or PI3K/AKT) signaling pathway inhibitor on benign prostate hyperplasia (BPH) and its mechanism.METHODS:Forty-eight SD male adult rats aged 12 weeks were equally randomized to 4 groups: sham operation control, BPH model, 50 mg LY294002 and 100 mg LY294002. The BPH models were made by muscular injection of testosterone propionate at 10 mg/kg/d for 30 days following castration. The LY294002 groups were treated with the PI3K/AKT signaling pathway inhibitor LY294002 at 50 and 100 mg/kg every other day for 30 days. The prostates of the rats were weighed and the structural changes of the prostatic histiocytes observed under the light microscope. The expressions of Ki-67, anti-apoptotic Bcl-2 and apoptotic Bax were detected by immunohistochemistry, and the apoptosis of prostatic cells determined by terminal de-oxynucleotidyl transferase-mediated dUTP nick end labeling.RESULTS:The prostate wet weight and prostatic index were (551 +/- 10.8) mg and 1.61 +/- 0.05 in the sham operation group, (687 +/- 13.8) mg and 2.15 +/- 0.12 in the BPH model group, (623 +/- 23.5) mg and 1.95 +/- 0.11 in the LY294002 50 mg group (P < 0.05 versus the BPH models) and (561 +/- 12.6) mg and 1.71 +/- 0.18 in the LY294002 100 mg group (P < 0.01 versus the BPH models). The expressions of apoptotic Bax and anti-apoptotic Bcl-2 were 16.7% and 16.7% in the sham operation group, 16.7% and 58.3% in the BPH model group, 33.3% and 33.3% in the LY294002 50 mg group (P < 0.05 versus the BPH models), and 50.0% and 25.0% in the LY294002 100 mg group (P < 0.01 versus the BPH models). The proliferative and apoptotic indexes were 14.2 +/- 6.4 and 6.5 +/- 1.8 in the epithelial and 7.6 +/- 2.6 and 2.5 +/- 0.3 in the interstitial tissue of the sham operation group, 50.9 +/- 12.8 and 2.7 +/- 1.4 in the epithelial and 16.5 +/- 5.7 and 1.3 +/- 0.8 in the interstitial tissue of the BPH models, 32.0 +/- 13.8 and 6.2 +/- 2.5 in the epithelial and 12.1 +/- 3.8 and 1.6 +/- 1.1 in the interstitial tissue of the LY294002 50 mg group (P < 0.05 versus the BPH models), and 17.8 +/- 14.7 and 7.4 +/- 3.6 in the epithelial and 9.5 +/- 3.4 and 2.2 +/- 1.3 in the interstitial tissue of the LY294002 100 mg group (P < 0.01 versus the BPH models).CONCLUSION:The increased proliferation and decreased apoptosis of prostatic cells in the BPH animal models might be involved in the development and progression of BPH. The PI3K/AKT signaling pathway plays an important role in the development of BPH, which could be inhibited by blocking the PI3K/AKT signaling pathway.

Effects of Inflammatory Responses, Apoptosis, and STAT3/NF-κB- and Nrf2-mediated Oxidative Stress on Benign Prostatic Hyperplasia Induced by a High-Fat Diet

Hypoxia-induced Autophagy Promotes Human Prostate Stromal Cells Survival and ER-stress

High-Fat Diet Induced Gut Microbiota Alterations Associating with Ghrelin/Jak2/Stat3 Up-Regulation to Promote Benign Prostatic Hyperplasia Development

The Therapeutic Effects of Docosahexaenoic Acid on Oestrogen/androgen-Induced Benign Prostatic Hyperplasia in Rats

Lack of Adiponectin and Adiponectin Receptor 1 Contributes to Benign Prostatic Hyperplasia

Role of P-Erk1/2 in Benign Prostatic Hyperplasia During Hyperinsulinemia.

High-fat diet impact on prostate gland from adiponectin knockout mice: Morphometric, metabolic and inflammatory cytokines analyses

Neferine Improves Oxidative Stress and Apoptosis in Benign Prostate Hyperplasia Via Nrf2-ARE Pathway.

Nrf2-mediated macrophage function in benign prostatic hyperplasia: Novel molecular insights and implications

Adiponectin Deficiency Contributes to the Development and Progression of Benign Prostatic Hyperplasia in Obesity.

Chronic inflammation promotes proliferation in the prostatic stroma in rats with experimental autoimmune prostatitis: study for a novel method of inducing benign prostatic hyperplasia in a rat model

Microbiome analysis reveals the inducing effect of Pseudomonas on prostatic hyperplasia via activating NF-κB signalling

Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging

Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation

High-fat diet-induced adipokine and cytokine alterations promote the progression of prostate cancer in vivo and in vitro .

SIRT3 affects mitochondrial metabolic reprogramming via the AMPK–PGC‐1α axis in the development of benign prostatic hyperplasia

Effect of PI3K/AKT Inhibitor on Benign Prostate Hyperplasia and Its Mechanism:An Experimental Study

Individual and Combined Effect of Bisphenol A and Bisphenol AF on Prostate Cell Proliferation Through NF-κB Signaling Pathway

Effect of Hypertension on Cell Proliferation and Apoptosis in Benign Prostatic Hyperplasia

Role of Inflammation in Benign Prostatic Hyperplasia Development among Han Chinese: A Population‐based and Single‐institutional Analysis

Proinflammatory Cytokines in Prostate Cancer Development and Progression Promoted by High-Fat Diet